T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
Global Payments
GPN
|
+$2B |
| 3 |
NextEra Energy
NEE
|
+$1.82B |
| 4 |
Salesforce
CRM
|
+$1.51B |
| 5 |
Boeing
BA
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.43B |
| 5 |
Elevance Health
ELV
|
+$1.39B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
iShares MSCI India ETF
INDA
$6.58B
| $12.7M | ﹤0.01% |
378,700
| – | – |
|
1252
Moderna
MRNA
$25.4B
| $12.7M | ﹤0.01% |
795,011
-40,416
| -5% | -$597K |
|
|
ESPR
1253
DELISTED
Esperion Therapeutics
ESPR
| $12.5M | ﹤0.01% |
341,027
+5,115
| +2% | +$203K |
|
1254
Kinross Gold
KGC
$31.9B
| $12.5M | ﹤0.01% |
2,709,793
-174,543
| -6% | -$810K |
|
|
BCPC
1255
Balchem Corp
BCPC
$5.65B
| $12.5M | ﹤0.01% |
125,559
+105,828
| +536% | +$10.1M |
|
1256
Madrigal Pharmaceuticals
MDGL
$11.7B
| $12.3M | ﹤0.01% |
142,533
-88,337
| -38% | -$8.29M |
|
|
OPLN
1257
Openlane
OPLN
$4.33B
| $12.1M | ﹤0.01% |
490,910
-5,173,322
| -91% | -$133M |
|
|
ALDR
1258
DELISTED
Alder Biopharmaceuticals
ALDR
| $11.9M | ﹤0.01% |
633,121
-7,060,998
| -92% | -$80.8M |
|
|
TUES
1259
DELISTED
Tuesday Morning Corp
TUES
| $11.9M | ﹤0.01% |
7,549,535
| – | – |
|
1260
BHP
BHP
$222B
| $11.7M | ﹤0.01% |
265,825
+25,415
| +11% | +$1.19M |
|
1261
ePlus
PLUS
$2.31B
| $11.7M | ﹤0.01% |
306,702
+1,308
| +0.4% | +$50.4K |
|
1262
Markel Group
MKL
$22.8B
| $11.6M | ﹤0.01% |
9,853
+87
| +0.9% | +$98.8K |
|
|
DS
1263
DELISTED
Drive Shack Inc.
DS
| $11.6M | ﹤0.01% |
2,684,529
+2,630,262
| +4,847% | +$12.4M |
|
1264
CryoPort
CYRX
$766M
| $11.5M | ﹤0.01% |
703,186
+2,852
| +0.4% | +$57.2K |
|
1265
Unum
UNM
$14.7B
| $11.4M | ﹤0.01% |
384,894
-712
| -0.2% | -$21.1K |
|
1266
Scholar Rock
SRRK
$6.46B
| $11.4M | ﹤0.01% |
1,273,867
-29,880
| -2% | -$357K |
|
1267
Royal Gold
RGLD
$19.1B
| $11.3M | ﹤0.01% |
91,495
-8,270
| -8% | -$1.01M |
|
|
PHX
1268
DELISTED
PHX Minerals
PHX
| $11.3M | ﹤0.01% |
805,830
+4,003
| +0.5% | +$49K |
|
|
MDLA
1269
DELISTED
Medallia, Inc.
MDLA
| $11.2M | ﹤0.01% |
+409,809
| New | +$14.5M |
|
1270
Planet Fitness
PLNT
$3.71B
| $11.1M | ﹤0.01% |
192,584
+174,499
| +965% | +$12.3M |
|
|
SDC
1271
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $11.1M | ﹤0.01% |
+798,589
| New | +$13.3M |
|
|
BOLD
1272
DELISTED
Audentes Therapeutics, Inc
BOLD
| $11.1M | ﹤0.01% |
394,539
-232,342
| -37% | -$7.93M |
|
|
PS
1273
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $11.1M | ﹤0.01% |
659,581
-4,326,438
| -87% | -$93.2M |
|
|
XEC
1274
DELISTED
CIMAREX ENERGY CO
XEC
| $11.1M | ﹤0.01% |
230,893
-10,491
| -4% | -$497K |
|
1275
Qiagen
QGEN
$8.93B
| $11M | ﹤0.01% |
315,381
+36,240
| +13% | +$1.39M |
|
Similar funds
T. Rowe Price Associates's Q3 2019 Portfolio in Review
As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
- T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
- T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
- T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
- T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
- T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.
Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.